Next Quarterly Earnings
Tuesday, October 27, 2026
CW 44
Pre-Market
In 14 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novartis
Novartis is a leading global pharmaceutical company headquartered in Basel, Switzerland (CH). The company researches, develops, and distributes innovative medicines and therapies. Through scientific excellence in areas like oncology and gene therapy, Novartis improves patient health worldwide, offering groundbreaking healthcare solutions for a better quality of life.
Earnings preview
Novartis (NOT) will release its Q3 2026 financial results before the market opens on October 27, 2026. Analysts estimate an earnings per share (EPS) of 1.87 CHF and revenue of 12,104 million CHF. In the previous quarter (Q2 2026), the company reported an EPS of 1.95 CHF, which beat the estimate of 1.76 CHF by 11.2%.
Generated automatically from our data — as of 09/28/2026
Recap: the latest results
Novartis (NOT) reported its Q2 2026 financial results on July 21, 2026, before market open. The company reported earnings per share (EPS) of 1.95 CHF, beating the analyst estimate of 1.76 CHF by 11.2%. Quarterly revenue reached 11,664 million CHF. Following the announcement, the stock price rose by 1.98%.
Generated automatically from our data — as of 07/29/2026 Read the article →
Frequently asked questions
When will Novartis report its next quarterly earnings?
Novartis is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Novartis last report quarterly earnings?
Novartis last reported quarterly earnings on 7/21/2026 (Q2 2026). Earnings per share (EPS) came in at 1.95 CHF.
How often has Novartis beaten expectations?
Novartis has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Does Novartis pay a dividend?
For fiscal year 2025, Novartis paid a dividend of 3.70 CHF per share.
How do I add the Novartis earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
+2.6%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Dividend history
3.70 CHF
Last dividend (FY 2025)
29
Fiscal years covered
| Fiscal year | Dividend per share | Ex-date | Payment date |
|---|---|---|---|
| 2025 | 3.70 CHF | 3/10/2026 | 3/12/2026 |
| 2024 | 3.50 CHF | – | – |
| 2023 | 3.30 CHF | – | – |
| 2022 | 3.20 CHF | – | – |
| 2021 | 3.10 CHF | – | – |
| 2020 | 3.00 CHF | – | – |
| 2019 | 2.95 CHF | – | – |
| 2018 | 2.85 CHF | – | – |
| 2017 | 2.80 CHF | – | – |
| 2016 | 2.75 CHF | – | – |
| 2015 | 2.70 CHF | – | – |
| 2014 | 2.60 CHF | – | – |
… and 17 more fiscal years
Source: Novartis investor relations, 29 fiscal years.
Past dividends are no guarantee of future payouts.
Company Information
Name
Novartis
Country
Index membership
More Financial Information